Typhoid Conjugate Vaccine

A single dose of a typhoid conjugate vaccine provided protection for at least 4 years among children aged 9 months to 12 years enrolled in a phase 3 trial in Malawi, according to results published in The Lancet.

Last week, the White House unveiled its new COVID-19 plan, which includes a test-to-treat initiative and efforts to enhance surveillance of wastewater for variants. It was the top story in infectious disease.

Routine use of a typhoid conjugate vaccine with a catch-up campaign through age 15 years could prevent approximately 67 million cases and 826,000 deaths caused by typhoid fever over 10 years, according to a study.

Typhoid conjugate vaccine is safe and effective in children when given with meningococcal A vaccine as part of routine immunization.